Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March.
The item "Altman-Zscore" stands at 1.09 as of 09/30/2025.
As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Altman Zscore" stands at 1.09. This represents a decrease of -4.51 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -0.0375 percent compared to the value the year prior.
The 1 year change in percent is -0.0375.
The 3 year change in percent is 15.99.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Altman Zscore | 905,699,262,464.00 |
![]() | Johnson & Johnson - Altman Zscore | 486,508,953,600.00 |
![]() | AbbVie Inc - Altman Zscore | 399,570,305,024.00 |
![]() | Roche Holding AG - Altman Zscore | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Altman Zscore | 280,205,508,085.11 |